BIO MARKER FOR PREDICTING EARLY-RELAPSE AFTER OPERATION FOR LUNG ADENOCARCINOMA

摘要

PURPOSE: A biomarker for predicting initial recurrence after lung adenocarcinoma surgery by observing mutation of gene on a specific site is provided. CONSTITUTION: A biomarker for predicting initial recurrence after lung adenocarcinoma surgery contains chromosome sites 5q21.3, 7p11.2, 9q34.11, 10p11.22, 11p13, 11p15.1, 11p15.4, 12p13.31, 16p13.12, 16q22.1, 17q11.2 or 21q22.11 or nucleic acid sequence thereof. A method for predicting initial reoccurrence after lung adenocarcinoma surgery comprises: a step of extracting nucleic acids from cancer tissue or cancer cells; a step of hybridizing the nucleic acids with nucleic acids which selectively bind to the biomarker; and a step of detecting hybridization complex.